Peptomyc is proud to join CatalonioBio
CataloniaBio is an association of companies in the health and life sciences arena […]
Peptomyc receives 850K € from Spanish Mineco and European Commission joint fund
The project is financed by the Spanish Ministry of Economy […]
Peptomyc wins prize at EIT Health Summit
Barcelona 23-24th November 2016
Around 350 participants from 19 countries joined […]
Peptomyc completed a successful and constructive Briefing Meeting with the Innovation Task Force of the European Medicines Agency (EMA) at their headquarters in London, U.K.
Such Briefing Meetings provide a forum for early dialogue covering […]
Peptomyc completes Seed Funding of €1M
Funds will help company reach preclinical validation for lead candidate in glioblastoma – an aggressive and lethal brain tumor – and in other cancer indications.
[…]
Peptomyc receives a business grant from ACCIÓ
This second grant in 2 months further supports Peptomyc in its mission to bring novel Myc inhibitors closer to clinical use for cancer treatment.
[…]
Peptomyc succeeds in gaining first grant funding from the European Commission
This grant represents the first big step forward for the company as it looks for further funding from investors to bring its novel Myc inhibitors closer to clinical application in cancer.
[…]
VHIR´s Health Innovation Contest 2015: first place goes to Myc Inhibitory Peptide
Source: The Vall d´Hebron Institute of Oncology
[…]